Front Page
October 15, 2025
Upcoming Northwest ATTC Webinars: The Power of Affirming Care (Oct 29) and Gaming Disordered Clients (Nov 5)
Join the Northwest ATTC this fall for two back-to-back webinar sessions! Certificate of Attendance available to all attendees of the live sessions. The Power of Affirming Care in SUD Recovery October 29, 2025 | 12pm-1:pm PTRegister here!Sponsored by the Northwest ATTC and the Washington Recovery Alliance. Affirming care is more than a value—it is a vital…
October 14, 2025
RECORDING AVAILABLE: Pathways to Connection: Accessing Treatment for Opioid Use Disorder Across Washington State (Oct. 14, 2025)
The Bree Collaborative and UW Addictions, Drug & Alcohol Institute hosted a webinar, Pathways to Connection: Accessing Treatment for Opioid Use Disorder Across Washington State, on October 14, 2025. This webinar explored how individuals across Washington State access treatment for opioid use disorder (OUD), with a focus on the implementation of medications for opioid use disorder (MOUD) in a…
September 26, 2025
Carfentanil: What Are We Seeing in Washington State?
From the UW Center for Community-Engaged Drug Education, Epidemiology & Research at the Addictions, Drug & Alcohol Institute The DEA recently reported that more than 50,000 fake pharmaceutical pills were seized by law enforcement in Western Washington. The pills were labeled with “M30” and designed to look like oxycodone. In recent years such pills typically…
September 16, 2025
New ADAI Publication: Expanding the Contingency Management Workforce to Include Peer Specialists
Citation: Hartzler B, et al. Reason to expand the contingency management workforce: Coaching-to-criterion results for addiction professionals and peer specialists. Subst Use Addict 2025 (in press). [doi: 10.1177/29767342251363007] Contingency management (CM) is a type of behavior therapy that uses rewards to motivate people in treatment for substance use disorder. These rewards encourage positive treatment behaviors,…
September 8, 2025
CTN/ATTC Webinar: Characterizing and Enhancing Collegiate Recovery Programs (1.5 CME/CE; Sept 24, 11am PT)
Join the Northwest ATTC (at ADAI), the Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network for their next webinar: Characterizing and Enhancing Collegiate Recovery Programs: Results from a Methodology Project September 24, 2025, 11am – 12:30pm PTNoel Vest, PhD, Assistant Professor at Boston University School of Public Health1.5 CME/CE…
August 21, 2025
ADAI Small Grants: Fall Cycle is Open; Apply by October 15, 2025!
ADAI works to stimulate and facilitate UW research on alcohol and drug use and addiction through its Small Grants research program, which awards funds to UW researchers for pilot studies and developmental research. Applications for the fall cycle are now being accepted; apply by 5pm PT October 15, 2025! Research funded through the small grants program has…
NEW from CEDEER: Stimulants and Health: A Handout and Guide for Care Teams
Methamphetamine and cocaine can have serious health effects, but there are steps people can take support their health when they’re using. ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) has released a new handout, Stimulants and Health: Support for people who use cocaine and methamphetamine, that offers information on: An accompanying interactive guide is designed for…
August 20, 2025
WATCH: The Empathy Lens Project, a Short Film from NNLM
The Empathy Lens collection, developed by ADAI Information Team staff Meg Brunner, MLIS, and Erinn McGraw, BFA, features free photographs related to drug and alcohol use, prevention, treatment, recovery, and harm reduction. The goal of this project is to reduce stigma against people who use drugs and the services available to support them by encouraging the use of realistic, humanizing…
August 14, 2025
New from CEDEER: Kratom & 7-OH: What Do We Know About Use, Safety, and Overdose Risk?
Kratom is a plant from Southeast Asia. Two of its primary psychoactive components are mitragynine and 7-hydroxymitragynine (7-OH), both of which have opioid-like properties. Though it has been banned in several states, it remains legal in Washington State, where it can often be found for sale in gas stations or smoke shops. The FDA recommended…
August 5, 2025
Northwest ATTC’s Workforce Spotlight Series: Meet Kevin Sweet!
There is a national shortage of addiction care professionals, and societal needs for this workforce are projected to increase over the next decade. While many things contribute to this circumstance, one major challenge is the stigma that often surrounds people with substance use disorders and the care available to them. To reduce stigma about addiction…
Previous page Next page
